Journal profile · Medicine-General Medicine
Shanghai Jiaotong Daxue xuebao Yixue ban
ISSN 1674-8115 · Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) · China
FollowGet an email when its zone, impact factor or warning status changes
Shanghai Jiaotong Daxue xuebao Yixue ban: fully open access; APC charged, amount not published; review about 24 weeks (community reports); 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Shanghai Jiaotong Daxue xuebao Yixue ban is published by Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, MicroRNA in disease regulation and Cancer-related molecular mechanisms research, together about 19.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of the journal is to facilitate the development of science and technology, cultivate academic talents and enhance academic exchanges. The journal publishes cutting edge achievements, theories, technologies and experiences in the fields of basic medicine, clinical medicine and public health. The journal welcomes papers of the following types: original research article, review, special topic, expert forum, perspective, short essay, technology and methodology and case report. The target readers are professionals engaged in clinical medicine, basic medicine, public health, nursing studies, pharmacy and other related fields, such as clinicians, scientific researchers, education staff, medical students, etc.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editor-in-chief FAN XianqunPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine7.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology6.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.6%
- Cancer-related Molecular PathwaysMedicine5.4%
- Thyroid Cancer Diagnosis and TreatmentMedicine4.8%
- Gastric Cancer Management and OutcomesMedicine4.8%
- TGF-β signaling in diseasesBiochemistry, Genetics and Molecular Biology4.8%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q4 | 532/669 | 20th |
| General Biochemistry, Genetics and Molecular Biology | Q4 | 220/223 | 1st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.11LetPub ·
- h-index
- 2OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 869 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 2 |
| 2025 | 0 | 0 | 7 |
| 2024 | 0 | 0 | 4 |
| 2023 | 0 | 0 | 6 |
| 2022 | 0 | 0 | 3 |
| 2021 | 21 | 21 | 4 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 24 weeksLetPub ·
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CNY 5,600 | No | CC BY-NC-ND | |
| LetPub | CNY 5,600 | No | — | |
| Publisher website | CNY 400 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- RMB 400
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- case reportsThe columns include original research articles (basic research, clinical research, public health, evidence-based medicine, techniques and methods), reviews, sho…Length not stated
- original research articlesThe columns include original research articles (basic research, clinical research, public health, evidence-based medicine, techniques and methods), reviews, sho…Length not stated
- reviewsThe columns include original research articles (basic research, clinical research, public health, evidence-based medicine, techniques and methods), reviews, sho…Length not stated
- short articlesThe columns include original research articles (basic research, clinical research, public health, evidence-based medicine, techniques and methods), reviews, sho…Length not stated
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics
- Conflicts of interest
All articles need to disclose competing interest at the end of the text and the authors contribution shall be stated at the end of the text. Model summary
All articles need to disclose competing interest at the end of the text and the authors contribution shall be stated at the end of the text.
Source ↗Publisher website ·- Publication ethics
Plagiarism, forgery, falsification, improper authorship and multiple submission is prohibited. Model summary
Plagiarism, forgery, falsification, improper authorship and multiple submission is prohibited.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Before you submit
Four checks before submitting to Shanghai Jiaotong Daxue xuebao Yixue ban
- 1ScopeRecent output centres on Medical Imaging Techniques and Applications, MicroRNA in disease regulation.Check scope
- 2Article type and formatPrepare text, figures and references as the author guidelines ask.Author guidelines ↗
- 3FeesCNY 5,600 (DOAJ)Fee details
- 4Expected review timeabout 24 weeks · Community averageReview data
The checks are built from this page's data.
Profile
Publication details and official links
- Publisher
- Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science)
- Country or region
- China
- Language
- Chinese
- ISSN
- 1674-8115
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Shanghai Jiaotong Daxue xuebao Yixue ban
How long does peer review take at Shanghai Jiaotong Daxue xuebao Yixue ban?
Authors report an average review time of about 24 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Shanghai Jiaotong Daxue xuebao Yixue ban?
According to LetPub and DOAJ records, Shanghai Jiaotong Daxue xuebao Yixue ban is indexed in Scopus and DOAJ.
Is Shanghai Jiaotong Daxue xuebao Yixue ban open access, and what is the APC?
Shanghai Jiaotong Daxue xuebao Yixue ban is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .